Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00097708 · ClinicalTrials.gov registry record · Phase 3
Experimental Medication For the Treatment of Generalized Anxiety Disorder
A Phase 3 study, sponsored by Jazz Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 511
- Enrollment target
NCT00097708 is a Phase 3 study that has completed, run by Jazz Pharmaceuticals. The registered enrollment target is 511 participants.
The verdict
NCT00097708, a Phase 3 study, has completed, sponsored by Jazz Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 511 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether an experimental anti-anxiety medication is effective in the treatment of Generalized Anxiety Disorder.
Interventions
- DRUG experimental anti-anxiety drug
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 511 participants |
| Start Date | 2004-11 |
| Est. Completion | 2005-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00097708
The ClinicalTrials.gov registry entry for NCT00097708 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 511 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jazz Pharmaceuticals, which has 128 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which experimental anti-anxiety drug is the first listed.
NCT00097708 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00097708 about?
NCT00097708 is a clinical study titled "Experimental Medication For the Treatment of Generalized Anxiety Disorder". The purpose of this study is to determine whether an experimental anti-anxiety medication is effective in the treatment of Generalized Anxiety Disorder.
What is the current status of trial NCT00097708?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 511 participants. The study started on 2004-11. Estimated completion is 2005-12.
What interventions are being tested in trial NCT00097708?
The interventions under investigation include: experimental anti-anxiety drug (DRUG).
Who is sponsoring clinical trial NCT00097708?
This trial is sponsored by Jazz Pharmaceuticals, which has 128 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.